Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Carmela Cosenza

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Genes|October 27, 2022
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β<sup>0</sup>39-Globin Gene Editing and Induction of Fetal HemoglobinLucia Carmela Cosenza, Cristina Zuccato, Matteo Zurlo, et al.
Journal of Clinical Medicine|January 11, 2025
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 PandemicRoberto Gambari, Maria Rita Gamberini, Lucia Carmela Cosenza, et al.
Non-Coding RNA|April 27, 2023
The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5pChiara Papi, Jessica Gasparello, Matteo Zurlo, et al.
Hematology Reports|July 25, 2023
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report StudyMaria Rita Gamberini, Cristina Zuccato, Matteo Zurlo, et al.
Journal of Clinical Medicine|May 11, 2024
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin)Matteo Zurlo, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Molecular Therapy. Methods & Clinical Development|May 17, 2021
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β<sup>0</sup>39-thalassemia patientsLucia Carmela Cosenza, Jessica Gasparello, Nicola Romanini, et al.
Wellcome Open Research|September 19, 2022
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established DrugsMarco Prosdocimi, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Experimental Hematology|November 8, 2023
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemiaLucia Carmela Cosenza, Giovanni Marzaro, Matteo Zurlo, et al.
Genes|October 28, 2023
Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter SequencesAlessia Finotti, Jessica Gasparello, Cristina Zuccato, et al.
Experimental Cell Research|November 9, 2023
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cellsMatteo Zurlo, Jessica Gasparello, Marco Verona, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Genes|October 27, 2022
Co-Treatment of Erythroid Cells from β-Thalassemia Patients with CRISPR-Cas9-Based β<sup>0</sup>39-Globin Gene Editing and Induction of Fetal HemoglobinLucia Carmela Cosenza, Cristina Zuccato, Matteo Zurlo, et al.
Journal of Clinical Medicine|January 11, 2025
A β-Thalassemia Cell Biobank: Updates, Further Validation in Genetic and Therapeutic Research and Opportunities During (and After) the COVID-19 PandemicRoberto Gambari, Maria Rita Gamberini, Lucia Carmela Cosenza, et al.
Non-Coding RNA|April 27, 2023
The Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR) Is under Post-Transcriptional Control of microRNAs: Analysis of the Effects of agomiRNAs Mimicking miR-145-5p, miR-101-3p, and miR-335-5pChiara Papi, Jessica Gasparello, Matteo Zurlo, et al.
Hematology Reports|July 25, 2023
Effects of Sirolimus Treatment on Fetal Hemoglobin Production and Response to SARS-CoV-2 Vaccination: A Case Report StudyMaria Rita Gamberini, Cristina Zuccato, Matteo Zurlo, et al.
Journal of Clinical Medicine|May 11, 2024
Increased Expression of α-Hemoglobin Stabilizing Protein (AHSP) mRNA in Erythroid Precursor Cells Isolated from β-Thalassemia Patients Treated with Sirolimus (Rapamycin)Matteo Zurlo, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Molecular Therapy. Methods & Clinical Development|May 17, 2021
Efficient CRISPR-Cas9-based genome editing of β-globin gene on erythroid cells from homozygous β<sup>0</sup>39-thalassemia patientsLucia Carmela Cosenza, Jessica Gasparello, Nicola Romanini, et al.
Wellcome Open Research|September 19, 2022
A Rational Approach to Drug Repositioning in β-thalassemia: Induction of Fetal Hemoglobin by Established DrugsMarco Prosdocimi, Cristina Zuccato, Lucia Carmela Cosenza, et al.
Experimental Hematology|November 8, 2023
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemiaLucia Carmela Cosenza, Giovanni Marzaro, Matteo Zurlo, et al.
Genes|October 28, 2023
Effects of Mithramycin on BCL11A Gene Expression and on the Interaction of the BCL11A Transcriptional Complex to γ-Globin Gene Promoter SequencesAlessia Finotti, Jessica Gasparello, Cristina Zuccato, et al.
Experimental Cell Research|November 9, 2023
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cellsMatteo Zurlo, Jessica Gasparello, Marco Verona, et al.
Pageof 4